How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Yale Cancer Center

J. Lacy

Year in Review: Pancreatic Cancers

OncoAlert

M. Lewis

Localized Pancreatic Cancer Controversial Cases: Panel Discussion

2023 Johns Hopkins Updates in Gastrointestinal Cancers

M. Katz, A. De Jesus-Acosta, N. Zaidi, J. He, A. Narang, T. Bekaii-Saab

Interventional Delivery of CAR-T Therapy

Michael Soulen

Augmenting Standard Treatment Options in Pancreatic Cancer

Rachna Shroff

GI Controversies: Neoadjuvant Tx of Pancreatic Cancer and Liquid Bio…

OncoAlert

B. Westphalen

ASCO® 2023 Insights: "Alliance A021806 Data on Perioperative vs. Adj…

Insights from 2023 ASCO® Annual Meeting

A. Chawla, C. Ferrone

Year in Review: GI Radiation Oncology

OncoAlert

E. Miller

Updates on Pancreatic Cancer Treatment

The University of Kansas Cancer Center

A. Kasi

Is There a Role for Radiation Therapy in Borderline-Resectable Pancr…

Joseph Herman

ASCO® 2023 Insights: "Phase 3 PANOVA-3 Study - TTF Therapy Concomita…

Insights from 2023 ASCO® Annual Meeting

H. Babiker

ASCO® 2024 Insights: "GABARNANCE Trial - Gemcitabine + nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

M. Ikeda

Radiation Therapy for Pancreatic Cancer

Yale Cancer Center

K. Du

Updates on GI Radiation Therapy: Rectal, Pancreas, Esophagus, Gastri…

OncoAlert

N. Sanford

Latest Data in Pancreatic Cancer Therapeutics

MedNews Week

S. Reddy

ASCO GI 2023 Continuous Maintenance Capecitabine Dosing for Advanced…

ASCO GI 2023 Conference Coverage

R. Mukherji

Updates in Radiation Oncology Management of Pancreatic Cancer

The University of Kansas Cancer Center

D. Akhavan

Year in Review: Pancreatic Cancer Surgery

OncoAlert

S. Paiella